Skip to content

Neural correlates of chronic fatigue syndrome

Neural correlates of chronic fatigue syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20349
Enrollment
120
Registered
2013-12-09
Start date
2014-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic fatigue syndrome

Interventions

Cognitive behavioural therapy versus waitinglist

Sponsors

Donders Institute for neuroimaging, Radboud University Nijmegen Expert Centre for Chronic fatigue, Radboud UMC Nijmegen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • ≥ 18 years ≤ 65 years; • Women; • Able to speak read and write Dutch; • Predominantly right handedness; • Give written informed consent; Patients: • Meet the 1994 US centre for Disease Control and Prevention criteria for Chronic Fatigue Syndrome (revised 2003) • Severely fatigued, i.e. scoring ≥ 40 on the subscale fatigue severity of the Checklist Individual Strength (CIS); • Severely disabled; i.e scoring ≥ 700 in the Sickness Impact Profile r_08 (SIPr08) total score; Healthy control: • Scoring ≤ 35 on the subscale fatigue severity of the Checklist Individual Strength (CIS);

Exclusion criteria

Exclusion criteria: • Any injury to the right hand that confounds hand grip performance; • A maximal voluntary contraction (MVC) that exceeds the maximal dispersion of the hand grip device (>400 Newton) • (History of) long term use of anti-depressants, anti-anxiety medications, beta-blockers benzodiazepines, psychostimulants or sleep medication; • Current major depressive or bipolar disorder • (History of) Schizophrenia or delusional disorder. • (History of) Anorexia nervosa or bulimia nervosa • (History of) alcohol or substance abuse • Severe obesity (BMI ≥ 40) • Abnormal hearing or (uncorrected) vision; MRI Contraindications: • Irremovable metal objects in or around the body (e.g. braces, pacemaker, metal fragments, hearing devices); • Claustrophobia; • (History of) Epilepsy; • Possible pregnancy or breastfeeding;

Design outcomes

Primary

MeasureTime frame
- Blood Oxygenation Level Dependent (BOLD) signal as measured with functional Magnetic Resonance Imaging (fMRI) - Cerebral tissue properties as measured with Magnetic Resonance Imaging (MRI), Diffusion Tensor Imaging (DTI) and MR-spectroscopy. - Behavioural performance on computerized tasks - Fatigue severity: checklist individual strength (CIS)

Secondary

MeasureTime frame
- Subjective measurements, e.g. self-report questionnaires, visual analogue scales - NAA concentration as determined by MR-spectroscopy - Cortisol and cytokine protein concentrations from hair, saliva and blood samples

Contacts

Public ContactMarieke Schaaf, van der

Donders Institute

marieke.vanderschaaf@donders.ru.nl+31(0)24 3668236

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)